ReCGiP: Database of Reproduction Candidate Genes in Pigs based on bibliomics

Embryo Implantation

Pathway Foreground Gene Count & Ratio Background Gene Count & Ratio p-value q-value
Cytokine-cytokine receptor interaction 17 / 33.33% 275 / 3.42% 9.33E-13 None
Focal adhesion 12 / 23.53% 199 / 2.48% 4.75E-09 None
Cytokines 12 / 23.53% 229 / 2.85% 2.13E-08 None
TGF-beta signaling pathway 8 / 15.69% 87 / 1.08% 1.14E-07 None
Bladder cancer 6 / 11.76% 40 / 0.50% 3.60E-07 None
Pancreatic cancer 7 / 13.73% 69 / 0.86% 4.08E-07 None
Adherens junction 7 / 13.73% 72 / 0.90% 5.33E-07 None
Colorectal cancer 7 / 13.73% 86 / 1.07% 1.63E-06 None
GnRH signaling pathway 6 / 11.76% 94 / 1.17% 3.54E-05 None
Renal cell carcinoma 5 / 9.80% 67 / 0.83% 8.32E-05 None
Melanoma 5 / 9.80% 71 / 0.88% 1.08E-04 None
Cellular antigens 11 / 21.57% 480 / 5.98% 1.92E-04 None
Hematopoietic cell lineage 5 / 9.80% 81 / 1.01% 1.94E-04 None
Type I diabetes mellitus 4 / 7.84% 44 / 0.55% 2.23E-04 None
ECM-receptor interaction 5 / 9.80% 84 / 1.05% 2.28E-04 None
ErbB signaling pathway 5 / 9.80% 84 / 1.05% 2.28E-04 None
Endometrial cancer 4 / 7.84% 51 / 0.63% 3.78E-04 None
Regulation of actin cytoskeleton 7 / 13.73% 213 / 2.65% 4.20E-04 None
Toll-like receptor signaling pathway 5 / 9.80% 103 / 1.28% 5.59E-04 None
Small cell lung cancer 4 / 7.84% 85 / 1.06% 2.31E-03 None
Prostate cancer 4 / 7.84% 90 / 1.12% 2.82E-03 None
CAM ligands 5 / 9.80% 152 / 1.89% 2.97E-03 None
mTOR signaling pathway 3 / 5.88% 48 / 0.60% 3.98E-03 None
Cell adhesion molecules (CAMs) 6 / 11.76% 242 / 3.01% 4.45E-03 None
Non-small cell lung cancer 3 / 5.88% 53 / 0.66% 5.18E-03 None
Leukocyte transendothelial migration 4 / 7.84% 113 / 1.41% 6.17E-03 None
MAPK signaling pathway 6 / 11.76% 277 / 3.45% 8.37E-03 None
Glioma 3 / 5.88% 64 / 0.80% 8.54E-03 None
Epithelial cell signaling in Helicobacter pylori infection 3 / 5.88% 65 / 0.81% 8.89E-03 None
VEGF signaling pathway 3 / 5.88% 67 / 0.83% 9.63E-03 None
Fc epsilon RI signaling pathway 3 / 5.88% 70 / 0.87% 1.08E-02 None
Dorso-ventral axis formation 2 / 3.92% 24 / 0.30% 1.15E-02 None
Chronic myeloid leukemia 3 / 5.88% 72 / 0.90% 1.16E-02 None
Natural killer cell mediated cytotoxicity 4 / 7.84% 142 / 1.77% 1.32E-02 None
Thyroid Cancer 2 / 3.92% 29 / 0.36% 1.62E-02 None
Apoptosis 3 / 5.88% 88 / 1.10% 1.95E-02 None
T cell receptor signaling pathway 3 / 5.88% 89 / 1.11% 2.01E-02 None
Gap junction 3 / 5.88% 98 / 1.22% 2.56E-02 None
Progesterone-mediated oocyte maturation 3 / 5.88% 103 / 1.28% 2.90E-02 None
Cell cycle 3 / 5.88% 115 / 1.43% 3.80E-02 None
Axon guidance 3 / 5.88% 127 / 1.58% 4.84E-02 None
Arachidonic acid metabolism 2 / 3.92% 54 / 0.67% 4.84E-02 None
Acute myeloid leukemia 2 / 3.92% 54 / 0.67% 4.84E-02 None
Tight junction 3 / 5.88% 128 / 1.59% 4.93E-02 None

Query Genes

Cytokine-cytokine receptor interaction 5618;  3553;  3596;  3952;  3458;  3569;  5617;  3572;  3976;  355;  1956;  7422;  3977;  3589;  3082;  650;  7040;  
Focal adhesion 3688;  5594;  207;  3690;  3685;  1956;  7422;  387;  6714;  3675;  6696;  3082;  
Cytokines 3553;  3596;  3952;  3458;  3569;  5617;  3976;  7422;  650;  3589;  3082;  7040;  
TGF-beta signaling pathway 5594;  4087;  4088;  3458;  6667;  7040;  650;  387;  
Bladder cancer 4313;  5594;  4318;  999;  1956;  7422;  
Pancreatic cancer 5594;  207;  4087;  4088;  1956;  7422;  7040;  
Adherens junction 5594;  4087;  4088;  999;  1956;  387;  6714;  
Colorectal cancer 5594;  207;  4087;  4088;  1956;  7040;  387;  
GnRH signaling pathway 4313;  5594;  1081;  1839;  1956;  6714;  
Renal cell carcinoma 207;  3082;  5594;  7040;  7422;  
Melanoma 1956;  999;  5594;  207;  3082;  
Cellular antigens 3688;  1803;  3690;  999;  3685;  3572;  3135;  355;  3977;  3675;  4582;  
Hematopoietic cell lineage 3690;  3589;  3569;  3553;  3675;  
Type I diabetes mellitus 3135;  355;  3553;  3458;  
ECM-receptor interaction 3690;  3688;  6696;  3685;  3675;  
ErbB signaling pathway 6714;  1839;  1956;  207;  5594;  
Endometrial cancer 1956;  999;  5594;  207;  
Regulation of actin cytoskeleton 3688;  5594;  3690;  3685;  1956;  387;  3675;  
Toll-like receptor signaling pathway 3569;  3553;  5594;  207;  6696;  
Small cell lung cancer 3688;  207;  3685;  3675;  
Prostate cancer 2308;  1956;  5594;  207;  
CAM ligands 3082;  4313;  6696;  7040;  7422;  
mTOR signaling pathway 5594;  207;  7422;  
Cell adhesion molecules (CAMs) 3688;  3690;  999;  3685;  3135;  3675;  
Non-small cell lung cancer 1956;  5594;  207;  
Leukocyte transendothelial migration 4318;  3688;  4313;  387;  
MAPK signaling pathway 3553;  5594;  207;  355;  1956;  7040;  
Glioma 1956;  5594;  207;  
Epithelial cell signaling in Helicobacter pylori infection 6714;  1839;  1956;  
VEGF signaling pathway 6714;  5594;  207;  
Fc epsilon RI signaling pathway 5594;  207;  3596;  
Dorso-ventral axis formation 1956;  5594;  
Chronic myeloid leukemia 5594;  207;  7040;  
Natural killer cell mediated cytotoxicity 3135;  355;  3458;  5594;  
Thyroid Cancer 999;  5594;  
Apoptosis 355;  3553;  207;  
T cell receptor signaling pathway 3458;  207;  387;  
Gap junction 6714;  1956;  5594;  
Progesterone-mediated oocyte maturation 5241;  5594;  207;  
Cell cycle 4088;  7040;  4087;  
Axon guidance 3688;  5594;  387;  
Arachidonic acid metabolism 5742;  5743;  
Acute myeloid leukemia 5594;  207;  
Tight junction 6714;  207;  387;